Inhibition of HDAC2 to promote memory

Details for Australian Patent Application No. 2009322958 (hide)

Owner Massachusetts Institute of Technology President and Fellows of Harvard College The General Hospital Corporation

Inventors Tsai, Li-Huei; Fischer, Andre; Haggarty, Stephen; Tang, Weiping; Schreiber, Stuart L.; Holsen, Edward; Wagner, Florence; Moyer, Mikel P.

Agent Pizzeys

Pub. Number AU-A-2009322958

PCT Pub. Number WO2010/065117

Priority 61/119,698 03.12.08 US

Filing date 2 December 2009

Wipo publication date 10 June 2010

International Classifications

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

C07C 235/42 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/065117 Priority application(s): WO2010/065117

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322964-Genome editing in rats using zinc-finger nucleases

2009322956-Portable devices for touchless particulate matter removal